Gut–hormone triple agonists: clinical safety and metabolic benefits

Timo D. Müller; Matthias H. Tschöp

doi:10.1016/S0140-6736(22)02350-9

Gut–hormone triple agonists: clinical safety and metabolic benefits

Timo D. Müller, Matthias H. Tschöp

Medicine and Health

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Original language	English
Pages (from-to)	1826-1828
Number of pages	3
Journal	The Lancet
Volume	400
Issue number	10366
DOIs	https://doi.org/10.1016/S0140-6736(22)02350-9
State	Published - 26 Nov 2022

Access to Document

10.1016/S0140-6736(22)02350-9

Cite this

@article{dccf9123fb37414bad016d2f904dac51,

title = "Gut–hormone triple agonists: clinical safety and metabolic benefits",

author = "M{\"u}ller, {Timo D.} and Tsch{\"o}p, {Matthias H.}",

year = "2022",

month = nov,

day = "26",

doi = "10.1016/S0140-6736(22)02350-9",

language = "English",

volume = "400",

pages = "1826--1828",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

number = "10366",

}

TY - JOUR

T1 - Gut–hormone triple agonists

T2 - clinical safety and metabolic benefits

AU - Müller, Timo D.

AU - Tschöp, Matthias H.

PY - 2022/11/26

Y1 - 2022/11/26

UR - http://www.scopus.com/inward/record.url?scp=85142432260&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)02350-9

DO - 10.1016/S0140-6736(22)02350-9

M3 - Comment/debate

C2 - 36436519

AN - SCOPUS:85142432260

SN - 0140-6736

VL - 400

SP - 1826

EP - 1828

JO - The Lancet

JF - The Lancet

IS - 10366

ER -

Gut–hormone triple agonists: clinical safety and metabolic benefits

Access to Document

Other files and links

Cite this